AI Insight
An FDA-approved narcolepsy medication shows potential applications for treating other neurological conditions, suggesting it may unlock new therapeutic pathways in brain treatment. The article also discusses research involving long-lived human brain organoids, which represent significant advances in laboratory models for studying brain function and disease.
Why it matters
Repurposing existing FDA-approved drugs can dramatically accelerate treatment availability for new conditions by bypassing years of safety testing. The development of longer-lasting brain organoids could improve research capabilities for studying neurological disorders and testing potential therapies in more realistic lab models.
Understand the Science
Nature, Published online: 21 August 2026; doi:10.1038/d41586-026-02626-x
Nature staff discuss how an FDA-approved drug for narcolepsy could have promise beyond the condition, and the longest-lived human brain organoids yet.
Source: Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies